• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

产β-内酰胺酶的卡他莫拉菌和流感嗜血杆菌菌株对某些β-内酰胺类抗生素的影响

Influence of beta-lactamase-producing strains of Branhamella catarrhalis and Haemophilus influenzae on certain beta-lactam antibiotics.

作者信息

Johnsson J, Brorson J E

出版信息

J Antimicrob Chemother. 1983 Sep;12(3):269-71. doi: 10.1093/jac/12.3.269.

DOI:10.1093/jac/12.3.269
PMID:6605337
Abstract

Ampicillin, benzylpenicillin, cefaclor and cefuroxime were exposed to strains of Branhamella catarrhalis and Haemophilus influenzae with and without ability to produce beta-lactamase. The antibiotics were dissolved in phosphate buffer at pH 6, 7 and 8 and the mean enzyme activity was calculated from decrease in peak heights by the HPLC technique. Cefuroxime was the most stable drug regardless of pH. For the other antibiotics, changes in pH influenced the results. In infectious processes factors like pH and pCO2 show some variation. This fact may influence the interaction between beta-lactams and beta-lactamases.

摘要

氨苄西林、苄青霉素、头孢克洛和头孢呋辛分别作用于有或无β-内酰胺酶产生能力的卡他莫拉菌和流感嗜血杆菌菌株。将抗生素溶解于pH值为6、7和8的磷酸盐缓冲液中,并通过高效液相色谱技术根据峰高降低计算平均酶活性。无论pH值如何,头孢呋辛都是最稳定的药物。对于其他抗生素,pH值的变化会影响结果。在感染过程中,诸如pH值和二氧化碳分压等因素会有一些变化。这一事实可能会影响β-内酰胺类药物与β-内酰胺酶之间的相互作用。

相似文献

1
Influence of beta-lactamase-producing strains of Branhamella catarrhalis and Haemophilus influenzae on certain beta-lactam antibiotics.产β-内酰胺酶的卡他莫拉菌和流感嗜血杆菌菌株对某些β-内酰胺类抗生素的影响
J Antimicrob Chemother. 1983 Sep;12(3):269-71. doi: 10.1093/jac/12.3.269.
2
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.阿莫西林加克拉维酸对流感嗜血杆菌和卡他莫拉菌的体外活性。
Eur J Clin Microbiol. 1986 Dec;5(6):615-21. doi: 10.1007/BF02013284.
3
Characterization of the plasmid-mediated beta-lactamase in Branhamella catarrhalis, with special reference to substrate affinity.卡他布兰汉菌中质粒介导的β-内酰胺酶的特性,特别涉及底物亲和力。
J Antimicrob Chemother. 1985 Feb;15(2):139-49. doi: 10.1093/jac/15.2.139.
4
Antibacterial activity of nine oral antibiotics against Streptococcus pneumoniae, Haemophilus influenzae and Branhamella catarrhalis.
Scand J Infect Dis Suppl. 1983;39:106-8.
5
[Comparative activity of oral beta-lactam antibiotics against fifty strains of Haemophilus influenzae producing a beta-lactamase according to bacterial inoculum].[根据细菌接种量比较口服β-内酰胺类抗生素对五十株产β-内酰胺酶流感嗜血杆菌的活性]
Pathol Biol (Paris). 1994 May;42(5):375-7.
6
Upper respiratory tract infections. Ecological and therapeutic aspects of beta-lactamase production with special reference to Branhamella catarrhalis.上呼吸道感染。β-内酰胺酶产生的生态学和治疗学方面,特别提及卡他布兰汉菌。
Drugs. 1986;31 Suppl 3:116-21. doi: 10.2165/00003495-198600313-00026.
7
In vitro activity of cefdinir against respiratory pathogens isolated in Sicily with reference to beta-lactamase production.头孢地尼对西西里岛分离出的呼吸道病原体的体外活性及β-内酰胺酶产生情况
J Chemother. 1996 Jun;8(3):193-9. doi: 10.1179/joc.1996.8.3.193.
8
Killing rate and growth rate comparison for newer beta-lactamase-stable oral beta-lactams against Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis.新型β-内酰胺酶稳定的口服β-内酰胺类药物对肺炎链球菌、流感嗜血杆菌和卡他莫拉菌的杀菌率与生长率比较
Chemotherapy. 1992;38(1):7-13. doi: 10.1159/000238935.
9
The permeability barrier of Haemophilus influenzae type b against beta-lactam antibiotics.
J Antimicrob Chemother. 1983 Nov;12(5):435-49. doi: 10.1093/jac/12.5.435.
10
Transfer of beta-lactamase production in Branhamella catarrhalis.卡他布兰汉菌中β-内酰胺酶产生的转移
Scand J Infect Dis. 1983;15(2):225-6. doi: 10.3109/inf.1983.15.issue-2.17.

引用本文的文献

1
In vitro activity of amoxicillin plus clavulanic acid against Haemophilus influenzae and Branhamella catarrhalis.阿莫西林加克拉维酸对流感嗜血杆菌和卡他莫拉菌的体外活性。
Eur J Clin Microbiol. 1986 Dec;5(6):615-21. doi: 10.1007/BF02013284.
2
Isoelectric focusing of beta-lactamases from sputum and middle ear isolates of Branhamella catarrhalis recovered in the United States.对在美国分离出的卡他布兰汉菌痰液和中耳分离株中的β-内酰胺酶进行等电聚焦分析。
Drugs. 1986;31 Suppl 3:48-54. doi: 10.2165/00003495-198600313-00012.
3
Classification of beta-lactamases from Branhamella catarrhalis in relation to penicillinases produced by other bacterial species.
卡他布兰汉菌β-内酰胺酶与其他细菌产生的青霉素酶的分类关系。
Drugs. 1986;31 Suppl 3:40-7. doi: 10.2165/00003495-198600313-00011.
4
Sensitivity of Branhamella catarrhalis to oral antibiotics.
Drugs. 1986;31 Suppl 3:17-22. doi: 10.2165/00003495-198600313-00006.
5
Therapy of acute otitis media caused by Branhamella catarrhalis. Preliminary report.卡他布兰汉菌所致急性中耳炎的治疗。初步报告。
Drugs. 1986;31 Suppl 3:122-4. doi: 10.2165/00003495-198600313-00027.
6
In vitro activities of LY163892, cefaclor, and cefuroxime.LY163892、头孢克洛和头孢呋辛的体外活性。
Antimicrob Agents Chemother. 1988 Jan;32(1):131-3. doi: 10.1128/AAC.32.1.131.
7
Branhamella catarrhalis: an organism gaining respect as a pathogen.卡他布兰汉菌:一种日益受到重视的病原菌。
Clin Microbiol Rev. 1990 Oct;3(4):293-320. doi: 10.1128/CMR.3.4.293.
8
Molecular basis of the efficacy of cefaclor against Haemophilus influenzae.头孢克洛对流感嗜血杆菌疗效的分子基础
Antimicrob Agents Chemother. 1992 Nov;36(11):2569-72. doi: 10.1128/AAC.36.11.2569.